ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
132.936,72
-0,05%
S&P 500
5.752,00
0,12%
US Dollar vs BRL
5,44
0,03%
Bitcoin
65.485,64
0,46%
Brent Oil
70,995
0,06%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Frazier LifeSciences Acquisition Corporation (FLAC)

  7. Frazier LifeSciences Acquisition Corporation (FLAC) Notícias

FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FLAC
DataHoraFonteTítuloCódigoCompanhia
15/02/202312:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
02/12/202218:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/11/202215:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202218:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202218:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202210:00GlobeNewswire Inc.NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular DiseaseNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
22/11/202218:17Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202213:31Business WireFrazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
14/11/202220:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/11/202218:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
13/10/202218:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
26/09/202209:00GlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/07/202209:00Business WireNewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic DiseasesNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/03/202218:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
14/02/202219:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
31/01/202218:44Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
31/01/202218:41Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
17/05/202117:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:FLAC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
PDGR3
PDG REALT ON
BOV
AZEV4
AZEVEDO PN
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
CBEE3
AMPLA ENERG ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV3
AZEVEDO ON
BOV
RNEW4
RENOVA PN
BOV
HAGA3
HAGA ON
BOV
TCSA3
TECNISA ON
BOV
GFSA3
GAFISA ON
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados